Archived Insight | November 1, 2018
Medical and prescription drug cost trends, for both actives and non-Medicare retirees, are projected to be lower in 2019 than in previous years.
That’s the headline finding from Segal’s 2019 Health Plan Cost Trend Survey, which surveyed more than 100 managed care organizations (MCOs), health insurers, pharmacy benefit managers (PBMs) and third-party administrators (TPAs).
Looking for the 2021 survey? Read it now.
Share this page
Plan sponsors continue to use various cost-management strategies to grapple with ever-escalating health plan costs.
We asked the survey participants to rank the cost-management strategies implemented by group health plans in 2018. Here are the top five, compared with 2017.
Prescription Drug Cost Management Continues to Be Plan Sponsors’ Highest Priority Strategy |
||
2018 Top Five |
2017 Top Five |
|
|
|
In the full report, you’ll find examples of further strategies, based on our extensive surveying. We also cover where to focus cost-management efforts.
Download the ReportHealth, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate
Health, Compliance
Health, Public Sector, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
© 2024 by The Segal Group, Inc.Terms & Conditions Privacy Policy California Residents Sitemap Disclosure of Compensation Required Notices
We use cookies to collect information about how you use segalco.com.
We use this information to make the website work as well as possible and improve our offering to you.